<DOC>
	<DOCNO>NCT02465008</DOCNO>
	<brief_summary>The purpose study determine whether levobupivacaine effective acute postoperative pain treatment periprosthetic breast augmentation</brief_summary>
	<brief_title>Analgesic Effect Levobupivacaine Breast Augmentation</brief_title>
	<detailed_description>One common plastic surgery breast augmentation use prosthesis ( mammoplasty Surgery cohesive silicone gel prosthesis insubpectoral plane ) . Remains challenging management acute postoperative pain allow early discharge patient . To end follow objective propose : evaluate analgesic efficacy L-Bupivacaine 0.25 % v . Placebo ( saline ) administer irrigation surgical pocket bilaterally intraoperatively .</detailed_description>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Women &gt; 18 &lt; = 65 year Mammoplasty Surgery cohesive silicone gel prosthesis subpectoral plane ASA I II Informed consent sign Rejection patient ASA III high Other condition warrant inclusion medically indicate ( eg psychiatric illness ) . Allergy NSAIDs , local anesthetic / morphine Patients treat chronic pain Placement drain surgical need</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>postoperative</keyword>
	<keyword>Patient-reported</keyword>
</DOC>